These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20210782)

  • 1. Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.
    Elder JH; Lin YC; Fink E; Grant CK
    Curr HIV Res; 2010 Jan; 8(1):73-80. PubMed ID: 20210782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular biology of feline immunodeficiency virus (FIV).
    Kenyon JC; Lever AM
    Viruses; 2011 Nov; 3(11):2192-213. PubMed ID: 22163340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of FIV infection.
    Elder JH; Sundstrom M; de Rozieres S; de Parseval A; Grant CK; Lin YC
    Vet Immunol Immunopathol; 2008 May; 123(1-2):3-13. PubMed ID: 18289701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.
    Power C
    J Neurovirol; 2018 Apr; 24(2):220-228. PubMed ID: 29247305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants.
    McCrackin Stevenson MA; McBroom DG
    Am J Vet Res; 2001 Apr; 62(4):588-94. PubMed ID: 11327469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic and genetic analysis of feline immunodeficiency virus gag, pol, and env genes from domestic cats undergoing nucleoside reverse transcriptase inhibitor treatment or treatment-naïve cats in Rio de Janeiro, Brazil.
    Martins AN; Medeiros SO; Simonetti JP; Schatzmayr HG; Tanuri A; Brindeiro RM
    J Virol; 2008 Aug; 82(16):7863-74. PubMed ID: 18550661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.
    Bendinelli M; Pistello M; Lombardi S; Poli A; Garzelli C; Matteucci D; Ceccherini-Nelli L; Malvaldi G; Tozzini F
    Clin Microbiol Rev; 1995 Jan; 8(1):87-112. PubMed ID: 7704896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of the FIV Model to Study HIV Pathogenesis.
    Miller C; Abdo Z; Ericsson A; Elder J; VandeWoude S
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
    Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Intra-individual Lentiviral Evolution Rates: a Systematic Review of Human, Nonhuman Primate, and Felid Species.
    Krakoff E; Gagne RB; VandeWoude S; Carver S
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of APOBEC3 Lentiviral Restriction Factors in Cats.
    Troyer RM; Malmberg JL; Zheng X; Miller C; MacMillan M; Sprague WS; Wood BA; VandeWoude S
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31500260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing anti-HIV drugs in the FIV model.
    North TW; LaCasse RA
    Nat Med; 1995 May; 1(5):410-1. PubMed ID: 7585083
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.
    Hayes KA; Phipps AJ; Francke S; Mathes LE
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2399-405. PubMed ID: 10952586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.
    Savarino A; Pistello M; D'Ostilio D; Zabogli E; Taglia F; Mancini F; Ferro S; Matteucci D; De Luca L; Barreca ML; Ciervo A; Chimirri A; Ciccozzi M; Bendinelli M
    Retrovirology; 2007 Oct; 4():79. PubMed ID: 17971219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RNA-Directed Gene Editing Strategy for Attenuating the Infectious Potential of Feline Immunodeficiency Virus-Infected Cells: A Proof of Concept.
    Murphy BG; Wolf T; Vogel H; Castillo D; Woolard K
    Viruses; 2020 May; 12(5):. PubMed ID: 32380756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline immunodeficiency virus infection--causative agent of an acquired immunodeficiency syndrome in cats.
    Hartmann K
    Eur J Med Res; 1996 Nov; 1(12):547-50. PubMed ID: 9438159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral reservoirs of feline immunodeficiency virus in cats: a review.
    Eckstrand CD; Sparger EE; Murphy BG
    J Gen Virol; 2017 Aug; 98(8):1985-1996. PubMed ID: 28749325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIV Gag: virus assembly and host-cell interactions.
    Luttge BG; Freed EO
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):3-13. PubMed ID: 19910057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of feline immunodeficiency virus RNA by two nucleic acid sequence based amplification (NASBA) formats.
    Jordan HL; Scappino LA; Moscardini M; Pistello M
    J Virol Methods; 2002 May; 103(1):1-13. PubMed ID: 11906728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.